Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Haleon PLC Sponsored ADR ( (HLN) ) just unveiled an update.
On August 26, 2025, Haleon PLC announced the purchase and cancellation of 1,369,903 ordinary shares as part of the second tranche of its share buyback program initiated on July 31, 2025. This transaction, completed on August 22, 2025, reflects the company’s strategic move to manage its share capital and potentially enhance shareholder value, impacting the number of shares with voting rights and aligning with market regulations.
The most recent analyst rating on (HLN) stock is a Hold with a $11.00 price target. To see the full list of analyst forecasts on Haleon PLC Sponsored ADR stock, see the HLN Stock Forecast page.
Spark’s Take on HLN Stock
According to Spark, TipRanks’ AI Analyst, HLN is a Neutral.
Haleon PLC’s overall stock score reflects strong financial performance and efficient cash flow generation, offset by mixed technical indicators and moderate valuation. The earnings call provided a balanced view of strengths in international markets and challenges in North America. The company’s ability to navigate these challenges and capitalize on growth opportunities will be crucial for future performance.
To see Spark’s full report on HLN stock, click here.
More about Haleon PLC Sponsored ADR
Haleon PLC is a global leader in consumer health, focusing on delivering better everyday health with a human touch. The company offers products across six major categories, including Oral Health, Vitamins, Minerals and Supplements, Pain Relief, Respiratory Health, Digestive Health, and Therapeutic Skin Health. Its well-known brands, such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu, and Voltaren, are grounded in trusted science and innovation.
Average Trading Volume: 12,605,949
Technical Sentiment Signal: Buy
Current Market Cap: $44.03B
For an in-depth examination of HLN stock, go to TipRanks’ Overview page.